Patient factors related to the real-world adoption of 3 months of adjuvant chemotherapy (ACT) in patients with stage III colorectal cancer (CRC). This is an ASCO Meeting Abstract from the 2024 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback